The Latest Cardiac and Vascular News
MINNEAPOLIS–(BUSINESS WIRE)–Children’s Minnesota is pleased to announce a $2.5 million, state-of-the-art biplane neuroangiography suite—the region’s only facility dedicated to pediatric neurointerventional procedures. This advanced imaging technology brings new treatment options for children with a variety of cerebrovascular diseases, further expanding Children’s Minnesota’s neurosurgical capabilities. “With this advanced biplane neuroangiography suite, we are raising the bar for children in
FDA-approved IDE trial to evaluate the safety and effectiveness of the nOCT™ Imaging System to provide quality images for diagnostic assessment during endovascular intracranial aneurysm treatment and follow-up FDA-approved IDE trial to evaluate the safety and effectiveness of the nOCT™ Imaging System to provide quality images for diagnostic assessment during endovascular intracranial aneurysm treatment and follow-up
ALEXANDRIA, La., March 2, 2026 /PRNewswire/ — Life Recovery Systems (LRS) has received an Investigational Device Exemption (IDE) from the US Food and Drug Administration (FDA) for testing of the ThermoSuit System (TSS) in a pivotal trial of ischemic stroke patients. The previous SISCO…
By partnering with the Neuro Tech Forum, CardiacVascular News gives its audience a front row seat to where neuro innovation is headed. The event convenes founders, researchers, clinicians, and investors who are actively building and backing the next wave of neurotechnology. It is a strong editorial fit for CardiacVascular News’ […]
New clinical data show AI-driven gains in aneurysm growth detection, stroke interpretation accuracy, and radiology workflow efficiency across enterprise imaging environments. SAN MATEO, CA (February 4, 2026) – RapidAI, the pioneer of deep clinical AI and global leader in enterprise imaging, today announced details of 28 scientific abstracts accepted at the International Stroke Conference (ISC) […]
Company advances global neuro-intervention footprint with new CE-marked devices for vasospasm and stroke, and expanded U.S. indications for aspiration catheters. PLANO, Texas, Feb. 10, 2026 /PRNewswire/ — Vesalio, a global leader in vascular intervention, today announced CE Mark…
BOSTON, Feb. 04, 2026 (GLOBE NEWSWIRE) — Balt, Inc., a global technology leader in neurovascular devices, today announced the Premarket Approval (PMA) of the Squid™ liquid embolic agent. Squid is approved for the embolization of the middle meningeal artery (MMA) as an adjunct to usual care treatment in patients with large symptomatic chronic subdural hematoma(s) (cSDH).
Brainomix 360 Stroke Next Generation has been awarded the prestigious Red Dot Design Award for excellence in usability and innovation An industry-first net water uptake feature unlocks deeper insights into stroke injury that can better inform treatment decisions New research will be…
A Pivotal Step in Optimizing the ADAPT 2.0 Technique for Speed and Simplicity with a Single System Setup ADAPT 2.0 with the Zoom Stroke System CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced the commercial launch and first patient cases of the new Zoom 4S Catheter – an advanced aspiration thrombectomy […]
Inclusion in new Acute Ischemic Stroke guidelines underscores clinical utility of Phagenyx for accelerating recovery from swallowing difficulties (dysphagia) in stroke patients NASHVILLE, Tenn., Jan. 27, 2026 /PRNewswire/ — Phagenesis, a commercial-stage company with a first-of-its-kind…
